Christopher D. Delaney
Duke University(US)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Protein Degradation and Inhibitors, Epigenetics and DNA Methylation, Histone Deacetylase Inhibitors Research, CRISPR and Genetic Engineering
Most-Cited Works
- → DOT1L inhibits SIRT1-mediated epigenetic silencing to maintain leukemic gene expression in MLL-rearranged leukemia(2015)249 cited
- → A Non-catalytic Function of SETD1A Regulates Cyclin K and the DNA Damage Response(2018)121 cited
- → Histone Acetyltransferase Activity of MOF Is Required for MLL-AF9 Leukemogenesis(2017)47 cited
- → High-resolution characterization of gene function using single-cell CRISPR tiling screen(2021)43 cited
- → Pharmacogenomics of EGFR-targeted therapies in non–small cell lung cancer: EGFR and beyond(2015)25 cited
- → Therapeutic targeting Tudor domains in leukemia via CRISPR-Scan Assisted Drug Discovery(2024)8 cited
- → Tudor Domain-Focused CRISPR Dropout Screen Identifies SGF29 As a Novel Essential Gene in MLL-Rearranged Leukemias(2019)4 cited
- → Pathway Coessentiality Mapping Reveals Complex II is Required for de novo Purine Biosynthesis in Acute Myeloid Leukemia(2025)2 cited
- → Non-Catalytic Role of SETD1A Regulates DNA Repair in Leukemia(2016)1 cited